Clinical trial
Pharmacokinetics of Apixaban in Nephrotic Syndrome
NCT02599532 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetics of Apixaban in Nephrotic Syndrome
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2017
- Completion date
- June 28, 2019
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.